MYC and non-small cell lung carcinoma: Interestingly, we identified c-Myc as the downstream target of β-catenin, and based on the most recent study on non-small cell lung cancer, there remains the possibility that the transcriptional activation of NAT10 might be modulated by c-Myc in CRC [23].